Cell‐free microRNA‐148a is associated with renal allograft dysfunction: Implication for biomarker discovery
Chronic allograft dysfunction (CAD), the foremost cause of renal graft loss worldwide, is a serious challenge for most of the recipients. As the epigenetic era is emerging, epigenetic biomarkers especially microRNAs (miRNAs) may reflect the current stage of the disease and patient’s therapy response...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
Wiley
2019
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/164786 |
Similar Items: Cell‐free microRNA‐148a is associated with renal allograft dysfunction: Implication for biomarker discovery
- Osmolytes resist against harsh osmolarity: Something old something new
- The impact of tumor and gut microbiotas on cancer therapy; Beneficial or detrimental?
- Stem cell therapy: curcumin does the trick
- Tobacco and end stage renal disease: a multicenter, cross-sectional study in Argentinian Northern Patagonia
- Letter to the Editor: Additional considerations for addressing pain in people living with cystic fibrosis
- Putting people at the center of ecosystem restoration